Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Dec;107(4):1181–1191. doi: 10.1111/j.1476-5381.1992.tb13426.x

Involvement of nitric oxide in the regional haemodynamic effects of perindoprilat and captopril in hypovolaemic Brattleboro rats.

S M Gardiner 1, T Bennett 1
PMCID: PMC1907923  PMID: 1467839

Abstract

1. Male, homozygous Brattleboro (i.e. vasopressin-deficient) rats were chronically instrumented with pulsed Doppler flow probes and intravascular catheters, and were studied 5 h after a subcutaneous injection of an hyperoncotic solution of polyethylene glycol to render them hypovolaemic, and hence dependent on the renin-angiotensin system for maintenance of haemodynamic status. Pilot experiments showed that, in this model, primed infusion of perindoprilat (0.05 mg kg-1 bolus, 0.05 mg kg-1 h-1 infusion) or captopril (0.2 mg kg-1 bolus, 0.2 mg kg-1 h-1 infusion) just abolished the pressor effect of angiotensin I (120 pmol), and had similar initial hypotensive and renal hyperaemic vasodilator effects. 2. Perindoprilat had more sustained hypotensive, and mesenteric and hindquarters vasodilator effects than captopril in the presence of saline. In the presence of NG-nitro-L-arginine methyl ester (L-NAME 3 mg kg-1 h-1), the renal vasodilator effects of perindoprilat were unchanged, whereas the other haemodynamic effects of perindoprilat and captopril were reduced. Hence, in the presence of L-NAME, all haemodynamic effects of perindoprilat were greater than those of captopril. 3. The renal hyperaemic vasodilator effects of acetylcholine were abolished by L-NAME and by perindoprilat, and were markedly reduced by captopril. However, since perindoprilat and captopril caused such marked renal hyperaemic vasodilatation themselves, it is feasible this change in baseline status contributed to their effects. It is unlikely this could be a full explanation of the results, because the haemodynamic effects of lemakalim were unchanged under any experimental conditions. 4. Bradykinin alone, or in the presence of saline, caused mesenteric hyperaemic vasodilatation whereas, in the presence of perindoprilat or captopril, bradykinin caused marked renal and mesenteric vasoconstrictions. However, in the additional presence of L-NAME, the mesenteric vasoconstriction was reduced, yet the hypotensive effect of bradykinin was augmented. One possible explanation of these observations is that, in the presence of L-NAME and either perindoprilat or captopril, bradykinin caused marked coronary vasoconstriction, leading to a reduction in cardiac output. 5. Neither perindoprilat nor captopril impaired the pressor, or renal, mesenteric, or hindquarters vasoconstrictor effects of L-NAME. Indeed, in their presence, the effects of L-NAME were generally enhanced, consistent with perindoprilat and captopril causing activation of nitric oxide-dependent mechanisms that were subsequently inhibited by L-NAME.

Full text

PDF
1181

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamsson M., Fallgren B., Edvinsson L. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate). Br J Pharmacol. 1992 Jan;105(1):93–96. doi: 10.1111/j.1476-5381.1992.tb14216.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Batin P., Gardiner S. M., Compton A. M., Bennett T. Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats. Life Sci. 1991;48(8):733–739. doi: 10.1016/0024-3205(91)90087-r. [DOI] [PubMed] [Google Scholar]
  3. Batin P., Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats. Br J Pharmacol. 1991 Jun;103(2):1585–1591. doi: 10.1111/j.1476-5381.1991.tb09831.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cachofeiro V., Sakakibara T., Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension. 1992 Feb;19(2):138–145. doi: 10.1161/01.hyp.19.2.138. [DOI] [PubMed] [Google Scholar]
  5. Cowan C. L., Cohen R. A. Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers. J Pharmacol Exp Ther. 1992 Jan;260(1):248–253. [PubMed] [Google Scholar]
  6. Fasciolo J. C., Vargas L., Lama M. C., Nolly H. Bradykinin-induced vasoconstriction of rat mesenteric arteries precontracted with noradrenaline. Br J Pharmacol. 1990 Oct;101(2):344–348. doi: 10.1111/j.1476-5381.1990.tb12712.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gardiner S. M., Bennett T. Interactions between neural mechanisms, the renin-angiotensin system and vasopressin in the maintenance of blood pressure during water deprivation: studies in Long Evans and Brattleboro rats. Clin Sci (Lond) 1985 Jun;68(6):647–657. doi: 10.1042/cs0680647. [DOI] [PubMed] [Google Scholar]
  8. Gardiner S. M., Bennett T. Pressor contributions from angiotensin and vasopressin after polyethylene glycol. Am J Physiol. 1986 Oct;251(4 Pt 2):R769–R774. doi: 10.1152/ajpregu.1986.251.4.R769. [DOI] [PubMed] [Google Scholar]
  9. Gardiner S. M., Compton A. M., Bennett T., Palmer R. M., Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 1990 May;15(5):486–492. doi: 10.1161/01.hyp.15.5.486. [DOI] [PubMed] [Google Scholar]
  10. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic changes following hypovolemia in conscious rats. Am J Physiol. 1989 May;256(5 Pt 2):R1076–R1083. doi: 10.1152/ajpregu.1989.256.5.R1076. [DOI] [PubMed] [Google Scholar]
  11. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic effects of atrial natriuretic peptide or captopril in Brattleboro rats. Am J Physiol. 1988 Nov;255(5 Pt 2):R737–R743. doi: 10.1152/ajpregu.1988.255.5.R737. [DOI] [PubMed] [Google Scholar]
  12. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol. 1990 Nov;101(3):625–631. doi: 10.1111/j.1476-5381.1990.tb14131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br J Pharmacol. 1990 Nov;101(3):632–639. doi: 10.1111/j.1476-5381.1990.tb14132.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gardiner S. M., Kemp P. A., Bennett T., Bose C., Foulkes R., Hughes B. Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats. Br J Pharmacol. 1992 Apr;105(4):839–848. doi: 10.1111/j.1476-5381.1992.tb09066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gardiner S. M., Kemp P. A., Bennett T. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol. 1991 Jul;103(3):1725–1732. doi: 10.1111/j.1476-5381.1991.tb09854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gardiner S. M., Kemp P. A., Bennett T. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats. Br J Pharmacol. 1991 Nov;104(3):731–737. doi: 10.1111/j.1476-5381.1991.tb12496.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goldschmidt J. E., Tallarida R. J. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1991 Jun;257(3):1136–1145. [PubMed] [Google Scholar]
  18. Hajj-ali A. F., Zimmerman B. G. Nitric oxide participation in renal hemodynamic effect of angiotensin converting enzyme inhibitor lisinopril. Eur J Pharmacol. 1992 Mar 3;212(2-3):279–281. doi: 10.1016/0014-2999(92)90344-4. [DOI] [PubMed] [Google Scholar]
  19. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  20. Hutcheson I. R., Griffith T. M. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. Am J Physiol. 1991 Jul;261(1 Pt 2):H257–H262. doi: 10.1152/ajpheart.1991.261.1.H257. [DOI] [PubMed] [Google Scholar]
  21. Kerth P. A., Vanhoutte P. M. Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels. Am J Hypertens. 1991 Mar;4(3 Pt 2):226S–234S. doi: 10.1093/ajh/4.3.226s. [DOI] [PubMed] [Google Scholar]
  22. Moncada S., Rees D. D., Schulz R., Palmer R. M. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2166–2170. doi: 10.1073/pnas.88.6.2166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Muller A. F., Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats. Clin Sci (Lond) 1990 Oct;79(4):393–401. doi: 10.1042/cs0790393. [DOI] [PubMed] [Google Scholar]
  24. Theodorsson-Norheim E. Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput Biol Med. 1987;17(2):85–99. doi: 10.1016/0010-4825(87)90003-5. [DOI] [PubMed] [Google Scholar]
  25. Tomlinson K. C., Gardiner S. M., Bennett T. Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats. J Cardiovasc Pharmacol. 1990 Apr;15(4):562–568. doi: 10.1097/00005344-199004000-00006. [DOI] [PubMed] [Google Scholar]
  26. Wiemer G., Schölkens B. A., Becker R. H., Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991 Oct;18(4):558–563. doi: 10.1161/01.hyp.18.4.558. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES